Annual report [Section 13 and 15(d), not S-K Item 405]

Segments (Details)

v3.25.1
Segments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Stock-based compensation expense $ 5,852 $ 3,475
Reportable Segment    
Segment Reporting Information [Line Items]    
Nonclinical expenses 570 1,029
Clinical expenses 9,966 5,780
CMC expenses 5,106 1,855
Salaries, benefits and related costs 6,164 3,576
Stock-based compensation expense 2,402 1,318
Other 229 226
Research and development $ 24,437 $ 13,784